Benitec Biopharma Ownership | Who Owns Benitec Biopharma?
Benitec Biopharma Ownership Summary
Benitec Biopharma is owned by 23.95% institutional investors, 4.39% insiders, and 71.66% retail investors. Awm investment company is the largest institutional shareholder, holding 0% of BNTC shares. Franklin Biotechnology Discovery A is the top mutual fund, with 5.43% of its assets in Benitec Biopharma shares.
BNTC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Benitec Biopharma | 23.95% | 4.39% | 71.66% |
| Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
| Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Awm investment company | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Awm investment company | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Awm investment company | - | - | -625.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Awm investment company | - | - | -625.00K |
Sold Out
| Holder | Change |
|---|---|
| Awm investment company | -625.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 1 | - | 625,000 | - | 23 | - | 1 | - | - | - |
| Sep 30, 2023 | 1 | -93.75% | 23 | -100.00% | - | 0.00% | - | -100.00% | 1 | -66.67% |
| Jun 30, 2023 | 16 | -20.00% | 11,055,879 | -4.96% | 39 | 2.29% | 2 | -33.33% | 3 | -57.14% |
| Mar 31, 2023 | 20 | -13.04% | 11,633,366 | -5.48% | 41 | 2.09% | 3 | -72.73% | 7 | 16.67% |
| Dec 31, 2022 | 23 | 15.00% | 12,307,556 | -15.85% | 44 | 1.59% | 11 | -15.38% | 6 | 200.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin Biotechnology Discovery A | 573.22K | 5.43% | - |
| Franklin Biotechnology Discv A(acc)USD | 223.35K | 2.12% | - |
| Simplify Health Care ETF | 116.53K | 1.10% | 2.39K |
| Vanguard Institutional Extnd Mkt Idx Tr | 207.79K | 1.05% | -6.90K |
| Janus Henderson Hrzn Biotec E2 USD | 134.42K | 0.68% | 3.46K |
| Fidelity Extended Market Index | 49.07K | 0.25% | -5.21K |
| BlackRock Extended Equity Market K | 18.50K | 0.18% | -8.00 |
| NT Ext Equity Mkt Idx Fd - NL | 14.55K | 0.14% | - |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 11.72K | 0.11% | 36.00 |
| Northern Trust Extended Eq Market Idx | 9.77K | 0.09% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 11, 2023 | Boston Megan | Executive Director | Buy | $2.59 |
| Aug 11, 2023 | Boston Megan | Executive Director | Buy | $100.00K |
| Aug 11, 2023 | BUCHI J KEVIN | - | Buy | $5.18 |
| Aug 11, 2023 | BUCHI J KEVIN | - | Buy | $200.00K |
| Dec 09, 2021 | Oliveira Steven Michael | - | Buy | $32.13K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
| 2023 Q3 | 4 | - |
| 2023 Q2 | - | - |
| 2022 Q4 | - | - |
BNTC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools